{"schema_version":"secwatch.filing_event.v1","accession":"0000885725-26-000013","form_type":"8-K","ticker":"BSX","cik":"0000885725","company_name":"BOSTON SCIENTIFIC CORP","filed_at":"2026-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.920213+00:00","generated_at":"2026-05-16T01:20:14.399529+00:00","sec_items":["5.02","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Boston Scientific boosts buyback by $4B to $5B; appoints two new directors","bullets":["Board approved additional $4.0B stock repurchase authorization, total available now $5.0B.","Board expanded from 10 to 12; appointed Catherine R. Smith (CFO of Starbucks) and Christophe P. Weber (CEO of Takeda).","Smith and Weber will serve on audit and compensation committees; standard prorated compensation until 2026 annual meeting.","Former directors John Sununu and Yoshiaki Fujimori will not stand for re-election at 2026 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0000885725-26-000013","json":"https://secwatch.observer/filing/0000885725-26-000013.json","markdown":"https://secwatch.observer/filing/0000885725-26-000013.md","text":"https://secwatch.observer/filing/0000885725-26-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885725/000088572526000013/0000885725-26-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885725/000088572526000013/bsx-20260218.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T01:20:14.399529+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}